Plasma Amyloid Beta Peptides: An Alzheimer’s Conundrum or a More Accessible Alzheimer’s Biomarker?

Expert Review of Neurotherapeutics - United Kingdom
doi 10.1080/14737175.2016.1217156
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Simplified Β-Amyloid Peptides for Safer Alzheimer’s Vaccines Development

Human Vaccines
2010English

The Corticobasal Syndrome–Alzheimer’s Disease Conundrum

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2011English

Microbiosensor for Alzheimer’s Disease Diagnostics: Detection of Amyloid Beta Biomarkers

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2012English

Electrochemical Detection of Plasma Immunoglobulin as a Biomarker for Alzheimer’s Disease

Sensors
InstrumentationInformation SystemsElectronic EngineeringBiochemistryAnalytical ChemistryMolecular Physics,ElectricalAtomicMedicineOptics
2017English

Progranulin Haploinsufficiency Reduces Amyloid Beta Deposition in Alzheimer’s Disease Model Mice

Experimental Animals
GeneticsMolecular BiologyBiochemistryVeterinaryAnimal ScienceMedicineZoology
2018English

Alzheimer’s Disease Risk Variants Show Association With Cerebrospinal Fluid Amyloid Beta

Neurogenetics
Molecular NeuroscienceGeneticsCellular
2008English

Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Lipidation of Apolipoprotein E Influences Its Isoform-Specific Interaction With Alzheimer’s Amyloid Β Peptides

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2000English

Is the A-Beta Peptide of Alzheimer’s Disease an Antimicrobial Peptide?

Journal of Gerontology & Geriatric Research
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy